From professional translators, enterprises, web pages and freely available translation repositories.
pre-authorisation
administration
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
marketing authorisation holder
detentur ta ’ l- awtorizzazzjoni għat- tqegħid fis- suq
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
beoordeling ge- post-authorisation
post- authorisation l- awtorizzazzjoni ta ’
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
advance authorisation scheme (regeling voorafgaande vergunningen, „aas”)
skema ta’ awtorizzazzjoni bil-quddiem (advance authorisation scheme, “aas”)
Last Update: 2014-11-12
Usage Frequency: 1
Quality:
direct debit instructions carried out under a direct debit authorisation ;
direct debit instructions carried out under a direct debit authorisation ;
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
( b ) direct debit instructions carried out under a direct debit authorisation ;
( b ) direct debit instructions carried out under a direct debit authorisation ;
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
marketing authorisation application, aanwezig en functionerend is voordat en terwijl het product op de markt is. en
awtorizzazjoni għat- tqegħid fis- suq, qegħda f’ postha u qed taħdem qabel u waqt li l- prodott qiegħed fuq is- suq. t ot
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
advance authorisation scheme (regeling voorafgaande vergunningen, vroeger bekend als advance licence scheme);
l-iskema ta’ awtorizzazzjoni bil-quddiem (magħrufa qabel bħala skema ta’ liċenzjar bil-quddiem);
Last Update: 2014-11-12
Usage Frequency: 1
Quality:
marketing authorisation holder bayer healthcare ag bayer healthcare ag d-51368 leverkusen d-51368 leverkusen duitsland duitsland
bayer healthcare ag
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
authorisation application (aanvraag van de vergunning voor het in de handel brengen) en elke volgende update van het rmp door de chmp akkoord is bevonden. mi
fl- aġġornamenti sussegwenti tal- rmp mifthema mas- chmp.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
voor het indienen van de vereiste gegevens raadpleegt de aanvrager de 'guidelines of the european food safety authority for the presentation of an application for safety assessment of a substance to be used in food contact materials prior to its authorisation'.
għas-sottomissjoni tad-data meħtieġa, l-applikant għandu jikkonsulta "l-linji gwida ta'l-awtorità ewropea dwar is-sigurezza ta'l-ikel għall-presentazzjoni ta'applikazzjoni għall-istima ta'sigurezza ta'sustanza li għandha tintuża f'materjali li jiġu f'kuntatt ma'l-ikel qabel l-awtorizzazzjoni tagħha".
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Reference:
Warning: Contains invisible HTML formatting
de vergunninghouder dient zich ervan te overtuigen dat het farmacovigilantiesysteem, zoals omschreven in versie 6.2 van module 1.8.1 van de marketing authorisation application in gebruik is en functioneert in de periode voordat en terwijl het product op de markt is.
l- mah għandu jassikura li s- sistema ta 'farmakoviġilanza, kif deskritta f' verżjoni 6. 2 u ppreżentata f' module 1. 8. 1. ta' l- applikazzjoni ta 'l- awtorizzazzjoni għat- tqegħid fis- suq, tkun stabbilita u qegħda taħdem qabel u waqt li l- prodott qiegħed fis- suq.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
de houder van de vergunning voor het in de handel brengen moet ervoor zorgen dat het farmacovigilantiesysteem, zoals dat in versie 2.1 wordt beschreven in module 1.8.1. van de marketing authorisation application, aanwezig en functionerend is voordat en terwijl het product op de markt is.
id- detentur ta ’ l- awtorizzazjoni għat- tqegħid fuq is- suq (mah) għandu jassigura li s- sistema ta ’ farmakoviġilanza, kif dettaljata fil- verżjoni 2. 1 ippreżentata f’ modulu 1. 8. 1. ta ’ l- applikazzjoni għal l- awtorizzazjoni għat- tqegħid fis- suq, qegħdha f’ postha u qed taħdem qabel u waqt li l- prodott qiegħed fuq is- suq.
Last Update: 2012-04-12
Usage Frequency: 4
Quality:
Reference: